<DOC>
	<DOCNO>NCT02835950</DOCNO>
	<brief_summary>The objective study ass safety , performance initial effectiveness TIVUS™ System use pulmonary artery denervation subjective objective change clinical parameter haemodynamic evaluation . This prospective , multi-center , non-randomized , open-label clinical trail . The study conduct 4 center recruit 15 patient diagnosed PAH , functional class III stable PAH stable drug regimen two pulmonary arterial hypertension specific medication .</brief_summary>
	<brief_title>TReatment Of Pulmonary HYpertension 1-US Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Patient know pulmonary arterial hypertension ( PAH ) , diagnose idiopathic PAH , connective tissue disease PAH , Anorexogen induce Heritable PAH PAH diagnosis confirm hemodynamic evaluation perform prior screen show follow : Mean pulmonary artery pressure ( mPAP ) ≥25 mmHg rest ; Pulmonary capillary wedge pressure ( PCWP ) leave ventricular end diastolic pressure ( LVEDP ) ≤15 mmHg ; Pulmonary vascular resistance ( PVR ) rest &gt; 3 Wood unit ; Not meet criterion positive vasodilator response ( fall mPAP ≥ 10 mmHg ≤ 40 mmHg ) . Patient current diagnosis WHO functional class III Patient take two pulmonary arterial hypertension specific medication parenteral prostanoids Patient adhere stable drug regimen ( i.e. , change dose medication minimum 3 month prior enrollment ) Patient eGFR level ≥ 30 ml/min/1.73m2or serum creatinine level ˂ 150µmol/l Patients treated parenteral prostanoids Pregnant woman woman plan pregnancy within 12 month study enrolment Patient significant comorbid condition ( ) , discretion PI , deem prohibit study entry Patient life expectancy less year Concurrent enrollment another device drug trial except observational study ( unless specifically approve sponsor ) Patient pulmonary artery anatomy preclude treatment Patient moderate severe pulmonary artery stenosis Patient pulmonary artery aneurysm Patient experience myocardial infarction , unstable angina pectoris , cerebrovascular accident previous 6 month Patient implantable cardiac pacemaker , ICDs , neurostimulators , drug infusion device Patients unable undergo MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>